{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 80"}, "official-title": {"#tail": "\n\t", "#text": "To provide for research and education with respect to\n\t\t  triple-negative breast cancer, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130103", "#text": "January 3, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": "\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Ms. Jackson Lee", "@name-id": "J000032"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H99F8D3764F9A46459FCABAE3F637B71B", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Triple-Negative Breast Cancer Research\n\t\t\t and Education Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H1E5332D3DF744D329A7550288261C4B2"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds as follows:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Breast cancer\n\t\t\t accounts for 1 in 4 cancer diagnoses among women in this country."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HB3542156620746E3A48046224F067C7A", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The survival rate\n\t\t\t for breast cancer has increased to 90 percent for White women and 78 percent\n\t\t\t for African-American women."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HB137BBA1257E4C389AB81B16520190E6", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "African-American\n\t\t\t women are more likely to be diagnosed with larger tumors and more advanced\n\t\t\t stages of breast cancer despite a lower incidence rate."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "H8A61E7DD09CE4613B765B5EA59247279", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Early detection\n\t\t\t for breast cancer increases survival rates for breast cancer, as evidenced by a\n\t\t\t 5-year relative survival rate of 98 percent for breast cancers that are\n\t\t\t discovered before the cancer spreads beyond the breast, compared to 23 percent\n\t\t\t for stage IV breast cancers."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H35FF91F900624F8599B9C3164818D1D2", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Triple-negative\n\t\t\t breast cancer is a term used to describe breast cancers whose cells do not have\n\t\t\t estrogen receptors and progesterone receptors, and do not have an excess of the\n\t\t\t HER2 protein on their sources."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HB5CA11B04D9E419F81103F8C2111C0D5", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "It is estimated\n\t\t\t that between 10 and 20 percent of female breast cancer patients are diagnosed\n\t\t\t with triple-negative breast cancer, and studies indicate the prevalence of\n\t\t\t triple-negative breast cancer is much higher."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "H6960B7CC35AD40508A527C8D8DA1B806", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Triple-negative\n\t\t\t breast cancer most commonly affects African-American women, followed by\n\t\t\t Hispanic women."}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H74A81F9497614F2B84DCC1A737B99775", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Triple-negative\n\t\t\t breast cancer is a very aggressive form of cancer which affects women under the\n\t\t\t age of 50 across all racial and socioeconomic backgrounds."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "H4CB5D84D469F453DB0DEF3667E473E17", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "African-American\n\t\t\t women are 3 times more likely to develop triple-negative breast cancer than\n\t\t\t White women."}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "H83AD472F29F84459B81727B5E72726CB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Triple-negative\n\t\t\t breast cancer tends to grow and spread more quickly than most other types of\n\t\t\t breast cancer."}, "enum": {"#tail": "\n        ", "#text": "(10)"}, "@id": "HDD27453D9F3F4D80B20813C771E2C43D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Like other forms\n\t\t\t of breast cancer, triple-negative breast cancer is treated with surgery,\n\t\t\t radiation therapy, or chemotherapy."}, "enum": {"#tail": "\n        ", "#text": "(11)"}, "@id": "HEECC47D2D43D47889E7EF30BE503AC7E", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Early-stage\n\t\t\t detection of triple-negative breast cancer is the key to survival because the\n\t\t\t tumor cells lack certain receptors, and neither hormone therapy nor drugs that\n\t\t\t target these receptors are effective against these cancers; therefore, early\n\t\t\t detection and education is vital."}, "enum": {"#tail": "\n        ", "#text": "(12)"}, "#text": "\n        ", "@id": "HCDACD976734D4BFC93C391CD05525FE3", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "Current research\n\t\t\t and available data do not provide adequate information on\u2014"}, "enum": {"#tail": "\n        ", "#text": "(13)"}, "#text": "\n        ", "@id": "H0FA4E91BC6634B12918EED1FC6088278", "@commented": "no", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the rates of\n\t\t\t prevalence and incidence of triple-negative breast cancer in African-American,\n\t\t\t Hispanic, and other minority women;"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H3A7A5243FD224B148291540400411ECD", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "he costs\n\t\t\t associated with treating triple-negative breast cancer; and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H06AA4C41F9D745A5B6EF102741F7C30C", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the methods by\n\t\t\t which triple-negative breast cancer may be prevented or cured in these\n\t\t\t women."}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "HDD27587484D24405BAB6BB9442057708", "#text": "\n          "}]}], "#text": "\n      ", "@id": "HBF2A8B817FF54CF59D54B1EC63C25A2B"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Research with\n\t\t\t respect to triple-negative breast cancer"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (in this section referred to as\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}, "term": {"#tail": ") shall expand, intensify, and coordinate\n\t\t\t programs for the conduct and support of research with respect to\n\t\t\t triple-negative breast cancer.", "#text": "Director of NIH"}, "#text": "The\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Research"}, "#text": "\n        ", "@id": "H9BB75821EDBD46B59C574AF1D384A104"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall carry out this section through the appropriate\n\t\t\t institutes, offices, and centers of the ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": ",\n\t\t\t including the ", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}, {"#tail": ", the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Eunice Kennedy Shriver National Institute of Child Health and\n\t\t\t Human Development"}, {"#tail": ", the\n\t\t\t ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Institute of Environmental Health Sciences"}, {"#tail": ", and the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Office of Research on Women\u2019s Health"}, {"#tail": ".", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National Institute on Minority\n\t\t\t Health and Health Disparities"}], "#text": "The\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Administration"}, "#text": "\n        ", "@id": "H0EC78C9C3BC94DDF9C9D88B1C0A91C2A"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall coordinate activities under this section among the institutes,\n\t\t\t offices, and centers of the ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the Office of Research on Women\u2019s\n\t\t\t Health"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "National Institutes of Health", "@entity-id": "7529"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Coordination of\n\t\t\t activities"}, "#text": "\n        ", "@id": "HE3FC985131EB4EA0AC06EF364206020F"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "$500,000 for each of the fiscal years\n\t\t\t 2014 through 2016", "@amount": "500000", "@year": "2014, 2015, 2016"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ",\n\t\t\t there are authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "this section", "@value": "Triple-Negative Breast Cancer Research and Education Act of 2013/s:3", "@proposed": "true"}, "#text": "For the purpose of carrying out ", "@name": "purpose"}}}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Authorization of\n\t\t\t appropriations"}, "#text": "\n        ", "@id": "H422D4C6FA65E4B6ABC02F586881DC7FF"}], "#text": "\n      ", "@id": "H867125F4FA1048F8A43238521D3C07F4"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Education and\n\t\t\t dissemination of information with respect to triple-negative breast\n\t\t\t cancer"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health\n\t\t\t and Human Services", "@entity-id": "7500"}, {"#tail": ", shall develop and disseminate to the public information\n\t\t\t regarding triple-negative breast cancer, including information on\u2014", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease\n\t\t\t Control and Prevention", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Triple-Negative\n\t\t\t breast cancer public education program"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the incidence and\n\t\t\t prevalence of triple-negative breast cancer among women;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H965FC7D610B4406BBB3C76D3879DCE6F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the elevated risk\n\t\t\t for minority women to develop triple-negative breast cancer; and"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HDD49364B2E8E450389E5A14EBA48147D", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the availability,\n\t\t\t as medically appropriate, of a range of treatment options for symptomatic\n\t\t\t triple-negative breast cancer."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "HF387759E94304D028F5499A4A7AFC305", "#text": "\n          "}], "#text": "\n        ", "@id": "H92E7F485286A436CAEA40A198D08665E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may disseminate information under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " directly or through arrangements with nonprofit organizations,\n\t\t\t consumer groups, institutions of higher education, Federal, State, or local\n\t\t\t agencies, or the media.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Triple-Negative Breast Cancer Research and Education Act of 2013/s:4/ss:a", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Dissemination of\n\t\t\t information"}, "#text": "\n        ", "@id": "H2FA28F9BB4A0435CAB4C99D1F334F66B"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "fiscal years 2014 through 2016", "@amount": "indefinite", "@year": "2014..2016"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ",\n\t\t\t there are authorized to be appropriated such sums as may be necessary for each\n\t\t\t of the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "this section", "@value": "Triple-Negative Breast Cancer Research and Education Act of 2013/s:4", "@proposed": "true"}, "#text": "For the purpose of carrying out ", "@name": "purpose"}}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Authorization of\n\t\t\t appropriations"}, "#text": "\n        ", "@id": "H721AD74AEBAD41CD9C8D4081E52637E2"}], "#text": "\n      ", "@id": "H9913EE0095384FF4BB88B301E548146F"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n\t\t\t", "#text": "Information to\n\t\t\t health care providers with respect to triple-negative breast cancer"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": ", shall develop and disseminate to health\n\t\t\t care providers information on triple-negative breast cancer for the purpose of\n\t\t\t ensuring that health care providers remain informed about current information\n\t\t\t on triple-negative breast cancer. Such information shall include the elevated\n\t\t\t risk for minority women to develop triple-negative breast cancer and the range\n\t\t\t of available options for the treatment of symptomatic triple-negative breast\n\t\t\t cancer.", "@entity-type": "federal-body", "#text": "Administrator of the Health\n\t\t\t Resources and Services Administration", "@entity-id": "7526"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Dissemination of\n\t\t\t information"}, "#text": "\n        ", "@id": "HC1AE5EC232104E04A7282DAFEA25E5B5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "#text": "fiscal years 2014 through 2018", "@amount": "indefinite", "@year": "2014..2018"}, "@entity-type": "auth-auth-approp", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}property": {"#tail": ",\n\t\t\t there are authorized to be appropriated such sums as may be necessary for each\n\t\t\t of the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "this section", "@value": "Triple-Negative Breast Cancer Research and Education Act of 2013/s:5", "@proposed": "true"}, "#text": "For the purpose of carrying out ", "@name": "purpose"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Authorization of\n\t\t\t appropriations"}, "#text": "\n        ", "@id": "HB94F99BDA68C47C9B3DF38F196956E48"}], "#text": "\n      ", "@id": "HB9B2A1939E4945039A68DA92E20EAC9A"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "term": {"#tail": " means women who are members of a racial and ethnic minority group,\n\t\t\t as defined in ", "#text": "minority\n\t\t\t women"}, "#text": "In this Act, the term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1707(g) of the Public Health Service Act", "@value": "Public Health Service Act/s:1707/ss:g"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 300u\u20136(g)", "@value": "usc/42/300u\u20136/g"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Definition"}, "#text": "\n      ", "@id": "H7D3C9C3E30D54088A5D66126856225E0"}], "#text": "\n\t\t", "@id": "H08A1AADC82B74DDF9518B5C0B9BB5722"}}}